DeepMed Research

Abramson Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.pennmedicine.org

Clinical Trials

Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer

Not Applicable

Withdrawn

Conditions: Adult Women With a New Diagnosis of Invasive Breast Cancer (Have Not Undergone Treatment)

Interventions: Other: 3'-deoxy-3'-[18F]fluorothymidine
Procedure: Positron Emission Tomography/computed tomography
Radiation: FLT-PET/CT

First Posted Date: 2009-11-23

Last Posted Date: 2015-12-15

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Registration Number: NCT01018251

Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Phase 1

Completed

Conditions: Non-small Cell Lung Cancer

Interventions: Radiation: fludeoxyglucose F 18
Radiation: Fluorine F 18 EF5
Procedure: Positron emission tomography

First Posted Date: 2009-11-20

Last Posted Date: 2012-09-26

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 56

Registration Number: NCT01017133

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Magnetic Resonance Imaging-Based Radiation Therapy and Cisplatin in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer

Not Applicable

Terminated

Conditions: Cervical Cancer

Interventions: Radiation: intracavitary balloon brachytherapy
Radiation: external beam radiation therapy
Radiation: intensity-modulated radiation therapy
Radiation: radiation therapy treatment planning/simulation
Radiation: 3-dimensional conformal radiation therapy
Drug: Cisplatin

First Posted Date: 2009-11-19

Last Posted Date: 2021-05-05

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 12

Registration Number: NCT01016561

Locations: 🇺🇸
Abramson Cancer Center of the Unviersity of Pennsylvania, Philadelphia, Pennsylvania, United States

Acupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Related Joint Pain

Not Applicable

Completed

Conditions: Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Recurrent Breast Cancer
Stage I Breast Cancer
Stage II Breast Cancer
Stage IIIC Breast Cancer

Interventions: Procedure: acupuncture therapy
Procedure: sham intervention

First Posted Date: 2009-11-13

Last Posted Date: 2020-04-08

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 76

Registration Number: NCT01013337

Locations: 🇺🇸
Abramson Cancer Center of The University of Pennsylvania, Philadelphia, Pennsylvania, United States

Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)

Not Applicable

Completed

Conditions: Lymphoma

Interventions: Radiation: Fludeoxyglucose F18
Procedure: Computed Tomography
Procedure: Positron emission tomography

First Posted Date: 2009-10-30

Last Posted Date: 2021-05-18

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 10

Registration Number: NCT01004718

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Acupuncture and Gabapentin for Hot Flashes Among Breast Cancer Survivors

Phase 2

Completed

Conditions: Hot Flashes

Interventions: Drug: Gabapentin

First Posted Date: 2009-10-30

Last Posted Date: 2020-04-15

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 120

Registration Number: NCT01005108

Locations: 🇺🇸
Abramson Cancer Center of the Unviersity of Pennsylvania, Philadelphia, Pennsylvania, United States

MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2009-09-24

Last Posted Date: 2019-04-24

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 3

Registration Number: NCT00984074

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer

Not Applicable

Terminated

Conditions: Cervical Cancer

Interventions: Radiation: fludeoxyglucose F 18
Radiation: fluorine F 18 EF5

First Posted Date: 2009-09-17

Last Posted Date: 2021-06-25

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 15

Registration Number: NCT00978874

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors

Phase 1

Completed

Conditions: Head and Neck Cancer
Precancerous Condition

Interventions: Drug: aminolevulinic acid hydrochloride

First Posted Date: 2009-09-16

Last Posted Date: 2019-04-23

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 35

Registration Number: NCT00978081

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation Therapy

Phase 1

Terminated

Conditions: Lung Cancer
Radiation Toxicity

Interventions: Other: placebo
Dietary Supplement: flaxseed

First Posted Date: 2009-08-10

Last Posted Date: 2020-04-02

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 48

Registration Number: NCT00955942

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy